LOS ANGELES–(BUSINESS WIRE)–Tombot, the robotics company that earned widespread acclaim at CES earlier this year for its lifelike robotic puppy, Jennie, announced today the successful close—and oversubscription—of its $6.1 million Series A funding round.

Tombot’s flagship product, Jennie, was designed specifically to treat the Behavioral and Psychological Symptoms of Dementia (BPSD) and other health issues.Share

“Tombot is entering a high-demand, underserved market at the intersection of mental health and assistive technology,” said Tombot CEO and Co-Founder Tom Stevens. “Over 300 million seniors around the world with dementia and mild cognitive impairment are unable to care for a live animal at a time when they need the companionship of a pet more than ever. Millions of other individuals suffering from mental health adversities are in a similar predicament.”

With artistic design by Jim Henson’s Creature Shop, and developed with the guidance of clinical experts, patients, and their families, Jennie provides many of the health benefits associated with live animal ownership, such as reduced stress and loneliness. Jennie will be used in private homes, assisted living and memory care communities, and other settings where live animals are not always safe or practical. Covered with sensors to respond to touch, voice commands, movement, and other sensory inputs, Jennie is rechargeable, fully cleanable, and comes with an optional caregiver app to customize behaviors and ease the burden of caregiving.

With participation from both new and existing investors, the funding round was led by Caduceus Capital Partners, a Nashville-based team of veteran healthcare investors with a primary emphasis on accelerating growth of early-stage digital health startups.

“We identified the growing need for robotic companions several years ago and believe the market is now on the brink of exponential expansion,” said Dave Vreeland, senior managing partner, Caduceus Capital Partners. “By 2030, the U.S. is projected to have 73 million seniors – an aging population that will increasingly face challenges related to loneliness, companionship, and chronic disease management. These issues are rapidly surpassing the capacity of human caregivers alone. Tombot is uniquely positioned to lead this emerging sector and drive widespread adoption of robotic companions.”

“This investment will be rocket fuel for Tombot,” said Stevens. “We are most appreciative of our company’s Board of Directors for their ongoing guidance, and are especially grateful to Caduceus for recognizing and supporting Tombot’s mission of creating robotic animals that transform the daily lives of individuals, families, and communities facing health adversities.”

According to Stevens, this milestone investment will be used to expand Tombot’s team, finalize engineering, complete regulatory and safety certifications, and prepare its first robotic pet for customer shipments to its more than 16,000 pre-order and waitlist customers.

About Tombot

Tombot, Inc., established in 2017, designs realistic robotic companion animals for individuals unable to safely or practically care for a live animal. After Tom Stevens’ own mother’s progressive dementia necessitated the rehoming of her beloved pet dog for safety reasons, Tom launched Tombot. Tombot’s flagship product, Jennie, was designed specifically to treat the Behavioral and Psychological Symptoms of Dementia (BPSD). The Tombot founding team built a prior startup into one of the world’s largest legal automation companies and was successfully acquired.

Contacts

Media Contacts:
Brotman•Winter•Fried Consulting
Laura Runcie
laura@aboutbwf.com; (201)707-9372

Steve Winter
swinter@aboutbwf.com; (202) 468-8100

(c)2025 Business Wire, Inc., All rights reserved.